Quincy Bioscience Congratulates Glen Campbell on Lifetime Achievement
Madison, Wisconsin (February 14, 2012) – Quincy Bioscience is proud to join the Recording Academy in congratulating Glen Campbell, American country music singer, as he is awarded the 2012 Grammy Lifetime Achievement award.
Glen Campbell has spent more than 50 years creating music that revolutionized the entertainment industry. Campbell courageously announced in June of 2011 that he has been diagnosed with Alzheimer’s disease and a result is performing his “Goodbye Tour” across the country.
Alzheimer’s disease is a progressive and degenerative brain disorder that results in memory loss and other forms of cognitive dysfunction. It is estimated that Alzheimer’s disease affects more than 5 million people in theUnited States.
Early last year, President Obama signed the National Alzheimer’s Project Act in order to get more attention for the research and treatment of Alzheimer’s disease.
In a recent USA TODAY article, Harry Johns, President of the Alzheimer’s Association said, “Back in the 1960’s, people didn’t talk about it. They were ashamed of it and wanted to hide it. We need to change that public discussion.”
Glen Campbell is doing just that; changing the public perception of Alzheimer’s disease by putting a spotlight on the need for more research and treatment options.
Quincy Bioscience, a biotechnology company based in Madison WI, has patented a unique protein, apoaequorin, which may prove effective in the fight against Alzheimer’s disease.
Quincy Bioscience presented data in July of 2011 at the annual Alzheimer’s Association International Conference in Paris, which demonstrated apoaequorin is able to significantly improve cognitive function for adults with memory concerns.
To read more about Quincy Bioscience and their groundbreaking research, please visit their website.
Media Contact:
Todd Olson
(608) 827-8134
tolson@quincybioscience.com
About Quincy Bioscience
Quincy Bioscience is a biotechnology company based inMadison,Wisconsin. Quincy Bioscience is focused on the discovery and development of novel compounds to fight the aging process. The company's technology focuses on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms.
Tags: